Are Oligodendrocytes the Missing Link in Amyotrophic Lateral Sclerosis Pathogenesis?

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/2001675

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Amyotrophic Lateral Sclerosis (ALS) is a debilitating and progressive neurodegenerative disease. Recent research suggests important cells of the central nervous system called glia play a role in disease onset and progression. We are interested in a type of glia called oligodendrocytes; they are crucial for supporting the survival of the cells that die in ALS. Only through understanding the underlying biology of ALS can we aim to identify effective therapies that will benefit patients.

Funded Activity Details

Start Date: 01-01-2020

End Date: 01-01-2025

Funding Scheme: Ideas Grants

Funding Amount: $1,054,405.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

brain metabolism | myelination | oligodendrocytes | stem cells

Related Links